GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human ferrochelatase mutant with phe 337 replaced by ala

Analyse Crystal structure of human ferrochelatase mutant with phe 337 replaced by ala in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2PNJ
Type
protein
Length
711 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ferrochelatase, mitochondrial
EC
4.99.1.1
UniProt
P22830
Ligands
CHD, FES
Pockets
10 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 50% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFerrochelatase, mitochondrial (EC 4.99.1.1)protein35550% helix, 15% strandP22830
BFerrochelatase, mitochondrial (EC 4.99.1.1)protein35649% helix, 15% strandP22830

Ligands and binding sites

  • CHD · Cholic acid · ligand · 6 copies · chains A, B
  • FES · Fe2/s2 (inorganic) cluster · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11090.780.9733empty
26990.780.8278FES, CHD
36350.760.8267CHD
4960.650.9026FES
52530.590.7924empty

Interfaces

1 interface between chains.

  • A–B · 1862 Ų buried · 31 hydrogen bonds · protein-protein

Compared structures

  • 2PNJ · Crystal structure of human ferrochelatase mutant with Phe 337 replaced by Ala · the same entry in another collection · chain A against A, TM-score 1.00
  • P22830 · AlphaFold monomer V2.0 prediction for ferrochelatase, mitochondrial (P22830) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.